MedPath

Home Monitoring in Hemophilia a

Recruiting
Conditions
Hemophilia a
Anticoagulant Therapy
Monitoring
Point of Care Testing
Qualitative Research
Registration Number
NCT06702579
Lead Sponsor
Radboud University Medical Center
Brief Summary

Rationale: A novel point-of-care device capable of measuring factor VIII (FVIII) activity and thrombin generation (TG) is currently under development. Utilization of this device in a home situation could potentially transform hemophilia care and improve patients' autonomy.

Objective: To explore the potential consequences of home monitoring of hemostatic parameters in patients with hemophilia A

Study design: Cross-sectional observational study consisting of semi-structured interviews and focus groups

Study population: Approximately 10 patients treated with vitamin K antagonists engaging in self-monitoring of coagulation at home and approximately 20 patients with hemophilia A.

Main study parameters/endpoints: The main outcome of this study is to assess series of interrelated themes related to the unmet needs of hemophilia patients and the envisioned potential consequences of home monitoring on these unmet needs.

Secondary outcomes include: identifying key features of a home monitoring platform to be used in hemophilia care, describing the experienced consequences of implementing home self-monitoring in anticoagulation treatment, assessing the current experiences of patients with self-monitoring, and providing an overview of the burdens and unmet needs experienced by patients with hemophilia with current hemophilia care.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The risk associated with participation in this study is negligible. Minor patients will be included in this study only if informed consent is given by both the patient and his/her caregiver (in patients between 12-16 years old). Gathering the insights of caregivers of minor patients on the current care for hemophilia and potential consequences of home self-monitoring is vital, as their experiences and needs might differ significantly from older patients. Participating in this study does not entail direct benefits. However, patients who participate can contribute to the development of future monitoring systems, which have the potential to alleviate the current burden of their disease and treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Semi structured interviews - identified themes on the potential impact of home monitoring in the care for patients with hemophilia AAt enrollment

Interrelated themes describing the current experiences and envisioned impact of home monitoring in hemophilia A, derived from analysis of semi-structured qualitative interviews (thematic analysis as described by Braun and Clarke (2006))

Secondary Outcome Measures
NameTimeMethod
Semi-structured interview - Themes describing the current experienced burdens and unmet needs for hemophilia A patients requiring prophylactic therapyAt enrollment

Interrelated themes describing current experienced burdens and unmet needs for hemophilia A patients requiring prophylactic therapy, derived from analysis of semi-structured qualitative interviews (thematic analysis as described by Braun and Clarke (2006))

Semi-structured interviews - Identified themes on the current experiences of patients receiving anticoagulation with coagulation home monitoringAt enrollment

Interrelated themes describing the experiences of patients receiving anticoagulation with coagulation home monitoring, derived from analysis of semi-structured qualitative interviews (thematic analysis as described by Braun and Clarke (2006))

Focus groups - Identified themes on healthcare providers' expectations regarding home monitoring in hemophilia AAt enrollment

Interrelated themes describing the expectations of healthcare providers on the impact of home monitoring in hemophilia A, derived from analysis of semi-structured qualitative interviews (thematic analysis as described by Braun and Clarke (2006))

Trial Locations

Locations (1)

Radboudumc

🇳🇱

Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath